DOTS implementation in a post-war, United Nations-administered territory: Lessons from Kosovo  by Tigani, Bahri et al.
ARTICLE IN PRESS
Respiratory Medicine (2008) 102, 121–1270954-6111/$ - see fro
doi:10.1016/j.rmed.
Corresponding au
E-mail address: gDOTS implementation in a post-war,
United Nations-administered territory:
Lessons from Kosovo
Bahri Tigania, Xhevat Kurhasanib, Lisa V. Adamsc, Gazmend Zhuria,b,
Rukije Mehmetib, Daniela Cirillod, Max Salfingere,f, Alka Devb,
Lucica Ditiug, Giovanni Battista Migliorih,aNational Tuberculosis Program, Prishtina, Kosovo
bDoctors of the World, New York, USA
cSection of Infectious Disease and International Health, Dartmouth Medical School, New Hampshire, USA
dOspedale S. Raffaele, Milano, Italy
eWadsworth Center, Albany, New York State Department of Health
fDepartment of Biomedical Sciences, School of Public Health, University at Albany, Albany, New York, USA
gBalkan Regional Office, World Health Organization, Bucharest, Romania
hWHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
Received 9 May 2007; accepted 25 July 2007
Available online 18 September 2007KEYWORDS
Stop TB strategy;
DOTS;
Kosovo;
TB controlnt matter & 2007
2007.07.027
thor. Tel.: +39 033
iovannibattista.mSummary
Setting: The WHO-recommended strategy of tuberculosis control (DOTS strategy) has
been shown to be effective in reducing tuberculosis incidence in a variety of countries/
settings. Little evidence exists on the implementation, and effectiveness of DOTS in a
transitional, post-war setting
Objective: To describe the process of establishing a National Tuberculosis Control Program
(NTP) and implementing DOTS throughout Kosovo, and the outcomes achieved by this
international collaboration in a post-war transitional setting during 1999–2005.
Methods: In 1999, as part of the re-organization of health services, a DOTS-based NTP was
established and operationalized through a collaboration of several international partners
in Kosovo. Five key steps supported these activities.
Results: Kosovo has reached the World Health Assembly targets, having achieved 75% case
detection rate (sputum smear-positive cases) and 93% treatment success rate. During
2000–2005, new smear-positive tuberculosis case notifications decreased by 44.5% (median
annual decrease for all cases: 7.6%).
Conclusions: Kosovo’s success story is a collaborative tale, each partner involved playing a
unique role in supporting NTP activities. The Kosovo example provides yet another settingElsevier Ltd. All rights reserved.
1 829404; fax:+39 0331 829402.
igliori@fsm.it (G.B. Migliori).
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B. Tigani et al.122in which DOTS implementation has resulted in successful patient outcomes. The
international TB control community would be well-served by formal guidelines for
implementing DOTS and the new STOP TB Strategy in these settings.
& 2007 Elsevier Ltd. All rights reserved.Introduction
DOTS, the World Health Organization (WHO)-recommended
strategy of tuberculosis (TB) control has been shown to be
effective in reducing TB incidence in a variety of countries
and settings.1–5 However, this evidence comes primarily
from politically stable settings where the National TB
Control Program (NTP) was able to implement the strategy
comprehensively, usually through a sequential process
consisting of a pilot phase, an expansion phase and,
eventually, a maintenance phase. However, little evidence
exists on the implementation, expansion, and effectiveness
of DOTS in a transitional, post-war setting. The situation in
Kosovo provides such an example.
Prior to 1999, the Serbian Ministry of Health (MOH) had
not implemented the DOTS strategy, the standard being
diagnosis by chest radiograph, hospitalization for 2 months
of treatment (initial phase) followed by outpatient treat-
ment for 4 months (continuation phase) at an Anti-TB
Dispensary (ATD) in the patient’s municipality of residence.
Sputum microscopy was performed at the hospital though
the diagnosis was rarely re-evaluated based on sputum
smear results. Standardized short-course therapy was used,
but streptomycin was preferred over ethambutol. At two
ATDs supported by the international non-governmental
organization (NGO) Doctors of the World, USA (DOW-USA),
diagnosis by sputum smear was encouraged and transporta-
tion of sputum specimens to smear microscopy laboratories
was facilitated.
On June 3, 1999, after NATO air strikes throughout Kosovo
and Serbia, an armistice was met, which included the return
of over one million ethnic Albanian refugees. A new political
infrastructure and leadership was established under the
administration of the United Nations Mission in Kosovo.
Health authorities in Kosovo had the rare opportunity to
establish a new NTP organizational structure, policies,
guidelines, and staffing. Unfortunately, the ensuing political
and economic instability and frequent turnover in leadership
positions affected the health system’s ability to provide
quality services. The political climate and tense relation-
ships between Albanian, Serbian, and Roma populations
within Kosovo created barriers to health care access. As a
result, Kosovo experienced a startling increase in the
number of active TB cases.
When we began TB control activities in the summer of
1999, Kosovo was in transition. We describe the process of
establishing the NTP and necessary infrastructure, implement-
ing DOTS throughout Kosovo, and the outcomes achieved by
this international collaboration in a post-war setting.aIn the absence of a national census, estimates of the population
range from 1.7 to 2.4 million. The estimate by UNMIK in 2000 was
2.0 million.Study population and methods
Kosovo, a territory of 10,927 km2, is located in the Balkans
(Figure 1). Previously a province under the Federal Republicof Yugoslavia, Kosovo has been administered by UNMIK since
the civil war ended in 1999. Of the approximately 2.0 million
inhabitantsa, 82% of pre-war (1991) and 88% of post-war
(2000) inhabitants describe themselves as Albanian. The
remainder of Kosovo’s population is comprised of Serbs
and other minority populations (7% and 5%, respectively,
in 2000).
In 1999, as part of the re-organization of health services,
a DOTS-based NTP was established and operationalized
through a collaboration of the following partners: DOW-USA,
the World Health Organization (WHO), Fogarty International
Center/National Institutes of Health-USA (FIC-NIH), Fonda-
zione S. Maugeri, S. Raffaele Hospital and Supranational
Reference Laboratory- SRL, Italy. First, we describe the role
each partner played in implementing DOTS throughout
Kosovo. Second, we review the outcomes achieved by this
international collaboration in a post-war setting.The partners and their roles
WHO was the lead agency for TB control and assisted the re-
organization of Kosovo’s public health infrastructure and
provided ongoing technical assistance to the NTP. WHO
coordinated the working group that developed Kosovo’s
5-year TB Action Plan 2000–2004 and facilitated the
implementation of several Action Plan components. After
2001, WHO supported human resources development,
supervision and monitoring of DOTS implementation/expan-
sion, and securing of funding from international donors
(e.g., contributions to applications to the Global Drug
Facility [GDF]—allowing provision of quality anti-TB drugs
at low cost—and Global Fund to Fight AIDS, TB and Malaria
[GFATM]—the main international source of funding presently
available against the three diseases).
DOW-USA is an international health, development, and
human rights NGO. Since 1994, DOW-USA had been im-
plementing a TB control project in Kosovo whose activities
included supervision of one ATD, establishment of quality-
controlled smear microscopy services at seven facilities and
culture capabilities at two hospital-based laboratories, and
training outreach health care workers. During the post-
conflict period, DOW-USA was the designated lead imple-
menting partner involved in all TB control activities
including provision of technical assistance and managerial
support to the NTP.
FIC-NIH supported the training of a physician in the
laboratory diagnosis of TB at the Wadsworth Center in
Albany, New York, USA and several courses in smear
microscopy for the laboratory technical staff at the Institute
of Public Health in Prishtina, Kosovo. Together with Kosovo’s
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Figure 1 Map of Kosovo.
DOTS Implementation in Kosovo 123health authorities and DOW-USA, FIC-NIH co-sponsored, the
first TB symposium in Kosovo in December 2002 for TB
specialists, family practitioners, public health nurses, and
laboratory staff.
WHO Collaborating, Centre for TB and Lung Disease,
Fondazione S. Maugeri and S. Raffaele Hospital and, SRL,
Italy. The WHO Collaborating Centre, Fondazione S. Maugeri
provided training in human resource development and
technical assistance to the NTP. The S. Raffaele Hospital
and Supranational Reference Laboratory (Milan/Rome) were
contracted to provide training to laboratory network
personnel and to develop Drug Resistance Surveillance
(DRS) protocols, necessary to monitor the prevalence of
resistance to anti-TB drugs in the region.The process
In 1999, national and international health leaders in Kosovo
drafted the official policy which dictated milestones for
health sector reform. WHO was authorized by UNMIK to
function as the executive health agency in the absence of an
MOH. In January 2000, the Kosovo Department of Health and
Social Welfare (DH&SW) was established as a regional MOH
for Kosovo co-led by national and UNMIK officials to pursue
the health sector reforms initiated by WHO. The former NTP
staff participated in the rebuilding of the new program
which was implemented in accordance with international
guidelines. An NTP Manager was identified through aselection process led by WHO. The Kosovo NTP was officially
launched on World TB Day in 2000.
The WHO office in Kosovo designated DOW-USA as the lead
partner for TB control activities planning and implementa-
tion. In close collaboration with the DH&SW, DOW-USA took
a leadership role on the TB Technical Commission, a newly
established advisory body of TB specialists. After developing
new Terms of Reference, the Commission drafted Kosovo’s
5-year TB Action Plan 2000–2004, based on the DOTS
Strategy. During the MOH re-organization and transition
period, DOW-USA assumed a managerial role for some NTP
activities and provided salary support to key NTP staff.
During 2003–2004, fiscal responsibility of three key NTP
positions supported by DOW-USA (NTP Manager, Laboratory
Network Coordinator, and Health Education Coordinator)
was gradually transferred to the DH&SW.
Individualized training in several components of the DOTS
Strategy (surveillance, data management, monitoring and
evaluation, laboratory network) was performed periodically
throughout 2000–2004 by international consultants. In
addition, senior NTP staff took part in various regional
workshops and international conferences and trainings.
Special sessions in TB control were conducted by NTP staff
for general practitioners and family medicine physicians.
The structure of the bacteriological laboratory network was
re-organized in accordance with international recommenda-
tions. DOW-USA hired a local microbiologist with interna-
tional experience to assess the TB laboratories’ needs, write
laboratory protocols, provide hands-on technical training, as
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Table 1. (continued )
Implementation of Directly Observed Therapy (DOT)
during the initial phase
d. An effective drug supply and management system
B. Tigani et al.124well as ordering consumables and equipment necessary for
high-quality and consistent services. The two hospital-based
laboratories were equipped with biosafety cabinets and
biosafety centrifuges; staff were trained in laboratory safety
procedures.Procurement of first-line drugs through Global Drug
Facility (GDF) since 2003
e. Monitoring & evaluation system, and impact
measurement
Implementation of Kosovo-wide proficiency testing
Certification of NRL by Supranational Reference
Laboratory in Rome, Italy
Establishment of eight Anti-TB Dispensaries (ATDs)
covering populations of 70,000–250,000 forResults
Implementation of NTP activities (based on the New
Stop TB Strategy)
The Kosovo TB Control Program’s achievements since 1999 in
the implementation and expansion of DOTS are summarized
in Table 1.Maintenance of TB registers
Completion of quarterly reporting on case finding
Completion of quarterly reporting on smear
conversion rates
Completion of quarterly reporting on treatment
outcomes
Development of a monitoring and evaluation plan,
including a plan of supervisory visits to the ATDs andEvaluation of impact indicators
Kosovo has reached the two World Health Assembly targets
(75% case detection rate of sputum smear-positive cases;
treatment success rate over 85%).6 TB case notifications are
summarized in Table 2. After an increase in 2000 (due toTable 1 NTP activities implemented in Kosovo
(1999–2006) (reported using the format recommended
in the New Stop TB Strategy document 5).
WHO STOP TB STRATEGY
1. Pursue high-quality dots expansion and enhancement
a. Political commitment with increased and sustained
financing
TB Action Plan 2000–2004
TB Action Plan 2005–2010 integrated in the Global
Fund to Fight AIDS, TB and Malaria (GFATM) 5-year
project proposal
Application to the GFATM approved in 2004 in the
amount of US $3,953,492.
b. Case detection through quality-assured bacteriology
Training on DOTS of 16 (80%) laboratory technicians
in smear microscopy
Development of a laboratory network
Eight direct smears laboratories
Two culture laboratories
One National Reference Laboratory (NRL) for Drug
Susceptibility Testing (DST)
Implementation of internal and external quality
assurance for smear microscopy laboratories
Training on DOTS of six NRL staff in mycobacterial
culture and DST
Implementation of Kosovo-wide proficiency testing
Certification of NRL by Supranational Reference
Laboratory in Rome, Italy
Implementation of Drug Resistance Surveillance (DRS)
started the last quarter 2006 according to the
principles of the DOTS expansion laboratory
subgroup.11
c. Standardised treatment, with supervision and patient
support
laboratories with checklists to facilitate accountability
Reporting of cohort data to WHO and Euro TB
2. Address TB/HIV, MDR-TB and other challenges
International Training of National TB Program (NTP)
Central Unit Staff
3. Contribute to health system strengthening
Selection of an NTP manager
Establishment of the NTP central unit in Prishtina
Training on DOTS of 60 (100%) specialists
Training on DOTS of 400 (90%) generalist physicians
Training on DOTS of 150 in-patient (100%)
International training of central unit NTP staff
4. Engage all care providers
Training on DOTS of two specialists, and 23 nurses in
minority areas
Establishment of two ATDs in minority areas
Improvement of minority communities access to:
Medications
Laboratory facilities for sputum testing
TB information
5. Empower people with TB and communities
Identification of a Minorities Coordinator (of Serbian
ethnicity) to:
Facilitate TB services provided in the Serbian and
Roma minority enclaves
Ensure practices are according to NTP guidelines
6. Enable and promote research
Development of operational research project in an
outpatient DOT center consisting in the
implementation of incentives distribution scheme (of
grocery coupons) in the municipality of Ferizaj
Use of results of this evaluation to develop
continuation phase DOT protocols (since rifampin is
used in the continuation phase)
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Table 2 Overall and new sputum smear-positive (SS+) cases notified, numbers and rates, per 100,000 population, Kosovo,
2000–2005.
Year All forms TB New SS+TB
Number of cases Rate (per 100,000
population)
Number of cases Rate (per 100,000
population)
2000 1776 85.9 418 20.2
2001 1674 78.2 461 21.5
2002 1443 67.4 402 18.8
2003 1127 52.7 292 13.6
2004 1009 48.5 272 13.1
2005 1102 52.9 232 11.0
Table 3 Treatment outcomes of sputum smear-positive cases (SS+), Kosovo, 2001–2004.
Year Registered n Cured Completed Died Failed Defaulted Transferred Success
n % n % n % n % n % n % n %
2001 421 147 35 219 52 18 4 13 3 24 6 0 0 366 87
2002 402 226 56 138 34 6 1 9 2 21 5 2 0.5 364 91
2003 292 175 60 87 30 4 1 1 0.3 21 7 4 1 262 90
2004 272 193 71 61 22 5 2 1 0.4 7 3 5 2 254 93
Figure 2 Proportion of re-treatment cases among all pulmon-
ary TB cases, Kosovo, 2001–2005.
DOTS Implementation in Kosovo 125improved case detection and surveillance), the number and
rate of smear-positive TB case notifications began to
continuously decrease. During the period 2000–2005, new
smear-positive TB case notifications decreased by 44.5%
(median annual decrease for all cases: 7.6%).
Treatment outcomes are summarized in Table 3. Treat-
ment success among sputum smear-positive cases increased
by 6.9% between 2001 and 2004. The proportion of
cases cured also increased, from 35% in 2001 to 71% in
2004. A decrease of re-treatment cases among the total
number of pulmonary cases (from 7.8% in 2001 to 4.6%
in 2005) and among sputum smear-positive pulmonary cases
(from 18.6% in 2001 to 14.7% in 2005) was observed
(Figures 2 and 3).Figure 3 Proportion of re-treatment cases among sputum
smear positive cases, Kosovo, 2001–2005.Measurable success of laboratory strengthening
A quality-assurance scheme for direct smear examination
was modeled on New York State’s system and their use of
slide panels. The 1999 mean pre-training score for profi-
ciency in reading acid-fast bacilli slides among participating
laboratories was 67.5%. On repeat proficiency testing
conducted in August 2000, the mean score was 100%. Similar
high scores were achieved on re-testing in 2001 and 2002.
The most recent post-training results from January 2006
averaged a score of 95.6%, indicating retention of knowl-
edge and skills.
The same laboratory partners worked with the NTP to
develop a DRS protocol and began assessing proficiency of
drug susceptibility testing (DST) in 2004, in collaboration
with Italian Supranational Reference Laboratories (Rome
and Milan). Laboratory experts of the San Raffaele Hospital
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of laboratory proficiency testing. Results from the second
round in September 2005 were successful: the laboratory
scored 100% on the parameters set by WHO for first line DST.Other successes
In late 2002, the Kosovo NTP, in collaboration with DOW-
USA, developed a successful application to the GDF which
resulted in a 3-year supply of free first-line anti-TB drugs
for all TB patients in Kosovo. In 2004, the NTP, under the
guidance of the Kosovo Coordinating Mechanism and with
technical assistance from WHO, DOW-USA and Fondazione
S. Maugeri, prepared a successful Round 4 proposal to the
GFATM.Discussion
Implementation of the DOTS strategy has not been eval-
uated in a post-war, transitional setting. DOTS implementa-
tion in Kosovo following the 1999 conflict and the laudable
epidemiological outcomes6,7 demonstrate that DOTS can be
successfully implemented and TB control achieved even
when a region is re-building its political and healthcare
infrastructure. Throughout DOTS implementation in Kosovo,
it remained under ‘‘temporary’’ UN-administration, and
experienced frequent changes in leadership and slow
financial recovery. Kosovo’s political issues, particularly
the question of its sovereignty, are far from being resolved.
However, the establishment and implementation of its NTP
is a noteworthy success story. Although the study was unable
to compare the TB control program effectiveness with that
of other programs, the Kosovo example further supports the
notion that investment in TB control is an effective use of
resources.8
There are many regions in the world in a situation
comparable to Kosovo’s. What are the lessons to be gleaned
from the Kosovo example that may be applied to similar
settings such as Afghanistan, East Timor, Palestine, Lebanon,
Darfur, or Iraq after setting-specific adaptation? In docu-
menting this experience, we identified five elements thatTable 4 Summary of five key recommendations for
implementing DOTS in transitional, post-conflict settings.
1. Identify an authoritative agency (e.g., WHO) to
provide oversight and to delegate DOTS (re-)
implementation activities
2. Designate a lead implementing partner (e.g., an
international or national NGO)
3. Ensure regular communication between the partners
for coordination and accountability
4. Pay intensive attention to human resources
development and management from the outset
5. Utilize a consistent cadre of dedicated partners
(including consultants) for continuity in planning,
implementation, and provision of technical assistancesignificantly contributed to the success of Kosovo’s DOTS
implementation (Table 4).
Identify an authoritative agency (e.g., WHO)
to provide oversight and to delegate DOTS (re-)
implementation activities
Early in the process of health system re-structuring, WHO
assumed the responsibility (in the absence of an MOH) for TB
control. The planning milestones were defined based
on epidemiological data under the coordination of WHO,
taking into consideration the resources available on an
international level. WHO was able to consider the partners
on the ground in Kosovo to designate a lead implementing
partner.
Designate a lead implementing partner
(e.g., an international or national NGO)
DOW-USA was named the lead NGO to guide NTP develop-
ment and implementation. This helped to eliminate duplica-
tion and ‘‘turf battles’’ between organizations. Conse-
quently, the long-term planning performed jointly by the
NTP, the leading international implementing agency and the
other partners provided a clear and uniform directive.
Ensure regular communication between the
partners for coordination and accountability
Regular and frequent communication among all stake-
holders/partners through meetings, phone calls and email
was essential. Establishment of the TB Technical Commission
was the main forum for this communication.9 Meetings of
the Commission were chaired by the NTP Manager and
allowed partners to review and track progress against the
Action Plan and to collectively brainstorm solutions. If goals
were not met on time, the Program Manager had the support
of the lead implementing partner (DOW-USA) and the lead
technical agency (WHO) to demand results.
Pay intensive attention to human resources
development and management from the outset
Significant investments in human resources were made in
the early stages.5,10 WHO, as an impartial authority,
conducted the selection process for the NTP Manager. Many
NTP staff initially employed by DOW-USA received intensive
training and support before they transitioned to the Kosovo
NTP/DH&SW. Providing direct salary support to local
governmental positions is generally considered ‘‘unsustain-
able’’. While it can complicate the chain of command, in the
immediate aftermath of the war in Kosovo, direct financial
support to the NTP was necessary. Our experience shows it is
possible to terminate this support within 4 years. In
addition, we avoided the problem of internal absorption of
skilled technical staff by international agencies. When
providing this type of support it is important to gauge
salaries according to national norms rather than salaries
that international agencies tend to offer.
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(including consultants) for continuity in planning,
implementation and provision of technical
assistance
All the partners made long-term commitments to this
endeavor. A core team of international consultants was
engaged throughout the 5-year period. Professional mentor-
ing relationships between the NTP staff and the consulting
experts were developed over time, making each consulting
visit more efficient. These longstanding relationships
gradually evolved into collegial partnerships which sup-
ported the transition of authority and leadership to the
Kosovar NTP staff. The Kosovar NTP senior staff has now
firmly established itself in the international TB control
community.9
Remaining challenges
Despite Kosovo’s success in implementing DOTS and control-
ling TB, challenges remain. The NTP must now meet
standards set for European TB control programs.10,11 In
addition, the NTP is determining how best to integrate TB
control activities into primary health care services and
ensure sustainable drug management.10 Providing TB care to
the minority populations remains a significant challenge
which is only exacerbated by political tensions and episodic
violence in the region. Identifying healthcare workers who
can safely collaborate with both dominant and minority
populations is essential in any post-conflict setting. Security
of health workers must be paramount, and the protection
historically accorded medical personnel crossing ethnic
borders can no longer be assumed to exist. Funds from the
GFATM award are being devoted to all of these activities.
Conclusions
The example of Kosovo provides another setting in which
DOTS implementation has been successful. Kosovo’s story is
a collaborative tale—each partner played a unique role in
supporting TB control activities in the region. Based on our
experience, we propose five recommendations for imple-
menting DOTS in similar situations. The international TB
control community would be well served by formal guide-
lines for implementing DOTS and the new STOP TB Strategy
in post-conflict, transitional settings.5
Acknowledgments
We are grateful to Ms. Sheela Kalangi, Consultant, Doctors
of the World, USA, for her contribution to this project and to
Mr. Udo Bucholtz, Monitoring and Surveillance, World HealthOrganization, Geneva, Switzerland and Dr. Elizabeth Talbot,
Section of Infectious Disease and International Health,
Dartmouth Medical School, Lebanon, New Hampshire, USA
for their valuable contributions to the preparation of this
manuscript. In addition, we are grateful to the staffs of both
the National Tuberculosis Program in Kosovo and Doctors of
the World, USA. The DOW activities in Kosovo were funded
primarily by USAID. We wish to thank Drs. Lanfranco
Fattorini and Elisabetta Iona for their contribution in
implementing DRS and in revising the manuscript. Special
thanks to Rosella Centis and Lia D’Ambrosio, WHO Collabor-
ating Centre for TB and Lung Diseases, Tradate, Italy for
their editorial contribution. We dedicate this manuscript to
the TB patients of Kosovo who have entrusted us with the
privilege of providing their care.
Conflict of interest statement
None of the authors have a conflict of interest to declare
in relation to this work.References
1. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce
tuberculosis mortality and transmission in low- and middle-
income countries. Bull WHO 2002;80:217–27.
2. The World Bank. World development report 1993 – Investing in
health. New York, USA: Oxford University Press; 1993.
3. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for
worldwide tuberculosis control under the WHO DOTS strategy.
Lancet 1998;352:1886–91.
4. Dye C, Fengzeng Z, Scheele S, Williams B. Evaluating the impact
of tuberculosis control: number of deaths prevented by short-
course chemotherapy in China. Int J Epidemiol 2000;29:558–64.
5. Raviglione MC, Uplekar MW. WHO’s new Stop TB Strategy.
Lancet 2006;367:952–5.
6. World Health Organization. WHO Report 2006. Global tubercu-
losis control: surveillance, planning, financing. WHO/HTM/TB/
2006.362, WHO, Geneva, Switzerland; 2006.
7. World Health Organization. WHO Report 2005. Global tubercu-
losis control: surveillance, planning, financing. WHO/HTM/TB/
2005.349, WHO, Geneva, Switzerland; 2005.
8. Stop TB Partnership and World Health Organization. Global Plan
to Stop TB 2006-2015. WHO/HTM/STB/2006.35. WHO, Geneva,
Switzerland; 2006.
9. Tigani BA, Kurhasani XH, Zhuri G, et al. Building a national
tuberculosis control programme in Kosovo: a post-war success
story. Int J Tuberc Lung Dis 2005;11:s293.
10. Kuyvenhoven JV, Veen J. Recommendations for tuberculosis
control in medium burden countries in central Europe. The
Hague, The Netherlands: KNCV; 2006.
11. Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G,
Thomsen V. the WHO European Laboratory Strengthening Task
Force Recommended standards for modern tuberculosis labora-
tory services in Europe. Eur Respir J 2006;28:903–9.
